Swapnil Dylan Fernandes

Swapnil Dylan Fernandes

Auto-generated profile, based on publicly available information

Swapnil Dylan Fernandes

Department of Pharmaceutical Regulatory Affairs, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, NITTE (Deemed to be University), Mangaluru, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Therapeutic Advances in Drug Safety
Verified
Journal Article
Open access
NRNikhil Raj
Nikhil Raj
SFSwapnil Fernandes
Swapnil Fernandes
NCNarayana R. Charyulu
Narayana R. Charyulu
ADAkhilesh Dubey
Akhilesh Dubey
Ravi Gundadka ShriramRavi Gundadka Shriram
Ravi Gundadka Shriram
SHSrinivas Hebbar
Srinivas Hebbar
Regulatory approvals for the marketing of medicinal products authorize medical practitioners to prescribe drugs to a group of patients that are defined within the license of the medicinal product. However, such prescriptions are carried out in a controlled manner. Prior to being approved, the medicinal product will have been evaluated in a population pool containing fewer than 5,000 patients and in a predesigned environment where several factors may be lacking, such as the absence of women of childbearing potential, geriatric patients and paediatric patients. Therefore, it is not surprising that several major adverse drug reactions are detected only when the product has been prescribed to the general population. National and international regulatory bodies have devised systems for monitoring medicinal products after marketing, commonly known as postmarketing surveillance systems. Postmarketing surveillance refers to the process of monitoring the safety of drugs once they reach the market, after the successful completion of clinical trials. The primary purpose for conducting postmarketing surveillance is to identify previously unrecognized adverse effects as well as positive effects. The Yellow Card scheme, practiced in the United Kingdom and the Canada Vigilance Program adopted in the Canadian jurisdiction, are two of the most successful postmarketing surveillance systems implemented across the world. Therefore, this article intends to discuss postmarketing surveillance and its role in the context of the United Kingdom and Canadian jurisdictions with a view on presenting key aspects and measures that are employed for operating an efficient postmarketing surveillance system in regulated markets.

1 January 2019 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
SFSwapnil Dylan Fernandes
Swapnil Dylan Fernandes
Anoop Narayanan VAnoop Narayanan V
Anoop Narayanan V
LCLovely Joylen Castelino
Lovely Joylen Castelino
RCR. Narayana Charyulu
R. Narayana Charyulu

1 April 2019 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
SFSwapnil Dylan Fernandes
Swapnil Dylan Fernandes
RNR. Charyulu Narayana
R. Charyulu Narayana
Anoop Narayanan VAnoop Narayanan V
Anoop Narayanan V

1 January 2018 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
LCLovely Joylen Castelino
Lovely Joylen Castelino
VNV Anoop Narayanan
V Anoop Narayanan
SFSwapnil Dylan Fernandes
Swapnil Dylan Fernandes
PKPankaj Kumar
Pankaj Kumar
DSD S. Sandeep
D S. Sandeep

1 January 2020 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
SSSandeep Divate Sathyanarayana
Sandeep Divate Sathyanarayana
SFSwapnil Dylan Fernandes
Swapnil Dylan Fernandes
LCLovely Joylen Castelino
Lovely Joylen Castelino
Anoop Narayanan VAnoop Narayanan V
Anoop Narayanan V
Ravi Gundadka ShriramRavi Gundadka Shriram
Ravi Gundadka Shriram
Sathyanarayana SD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):69-75. https://doi.org/10.7774/cevr.2020.9.2.69